OTC:OCEA | Cash Flow Statement | Ocean Biomedical, Inc.

Complete source-backed cash-flow history.

Available history
2021-09-30 to 2025-03-31
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-03-31-$8.24M-$356,000.00$909,000.00
2024-12-31-$1.54M-$2.45M$2.43M
2024-09-30-$5.53M
2024-06-30-$17.23M
2024-03-31$13M-$485,000.00
2023-12-31-$16.86M-$866,000.00$839,000.00
2023-09-30-$14.09M
2023-06-30-$11.43M
2023-03-31-$72.09M-$2.65M$2.92M
2022-12-31-$983,000.00-$33,000.00-$1.05M-$49,000.00
2022-09-30-$3.67M
2022-06-30-$7.33M
2022-03-31-$5.38M-$367,000.00$599,000.00
2021-09-30-$42,627.00-$707,805.00-$107.1M$108.97M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2024-12-31-$9.48M-$4.18M$3.4M
2023-12-31-$114.47M-$9.43M$10.4M
2022-12-31-$17.36M-$993,000.00-$2.1M$967,000.00